Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times
Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here
Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday
Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore
Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times
Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times
Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares
Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here
Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.
Investors willing to apply for Meesho IPO can review the company's strengths and risks as outlined in its Red Herring Prospectus (RHP)
The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday
Wakefit Innonvation aims to raise ₹1,288 crore through a fresh issue of 19.3 million shares, amounting to ₹377.18 crore, and an OFS of 46.8 million shares, amounting to ₹911.7 crore
Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.
Ravelcare IPO received bids for 9.22 million equity shares compared to the issue size of 1.32 million shares
Vidya Wires IPO will open for subscription on Wednesday, December 3, 2025, and close on Friday, December 5, 2025
Sudeep Pharma shares opened at ₹733.95, a premium of ₹140.95 or 23.8 per cent
Sudeep Pharma IPO witnessed robust investor interest, getting oversubscribed 93.72 times overall, driven largely by strong participation from QIBs
Ravelcare has set the price band for its IPO in the range of ₹123 to ₹130 per equity share
Exato Technologies IPO is being offered at a price band of ₹133 to ₹140 per share, with a lot size of 1,000 shares
Sudeep Pharma IPO allotment: Investors can check their allotment status online through the official websites of the BSE, NSE, or MUFG Intime India